Healthcare is poised for a potential giant leap forward due to the 3D printing of medications. To advance the technology and science of 3D pharmaceutical printing, Purdue University’s College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.
 
“Aprecia’s mission is to maximize and expand its 3DP technology platform through global partnerships that will provide pharmaceutical solutions for unmet patient needs,” said Chris Gilmore, chief executive officer, Aprecia. “Purdue University is an esteemed institution, and we are confident that this partnership will advance our future in 3DP pharmaceutical research and development.”
 
In 2015, Aprecia Pharmaceuticals developed the first 3D printed medication to receive FDA approval.
 
According to Eric Barker, dean of Purdue’s College of Pharmacy, the agreement brings together an exchange of faculty and research scholars; access to highly-educated students; and joint collaborations in research and discovery, learning and teaching, engagement and technical assistance.
 
“Purdue University is committed to its investment in drug discovery and development as well as student and faculty enrichment that will continue to yield global advancement in medicine and healthcare,” said Barker. “As a college, our mission is to prepare the next generation of leaders in pharmacy. Partnering with Aprecia aligns perfectly with that mission. We are excited to combine our talented students and faculty with the successful researchers at Aprecia to work together to accelerate discoveries in this emerging field.”
 
Eric Munson, head of the Industrial and Physical Pharmacy Department, said that the collaboration will spur the development of advanced medications.
 
“Giving our faculty and students access to 3DP technology through research projects, internships, and joint collaborations advances our mission of educating and training students through scientific discovery and development,” Munson said. “Incorporating the latest technological developments, like 3DP, into our program are key to producing the best workforce in pharmaceutical formulation and manufacturing.”